In addition, administration of truncated mutant FILIP1L inhibited growth in human malignant melanoma tumor xenografts and serous cystadenocarcinoma cells by suppressing angiogenesis [12, 13]. Here, FILIP1L is linked to serous cystadenocarcinoma.